06/11/2024  17:06:23 Diferencia - Volumen Bid18/07/2024 Ask13:37:36 Capitalización de mecado Dividendo A. P/E Ratio
32.60EUR - 192
Volumen de negocios: 6,315.45
-Volumen de oferta: - -Tamaño/ Volumen/ Formato de Ask: - 387.77 millonesEUR 1.72% 29.81

Descripción de negocio

STRATEC SE designs and manufactures fully automated analyzer systems for its partners in the fields of clinical diagnostics and biotechnology. Furthermore, the company offers integrated laboratory software and complex consumables for diagnostic and medical applications. STRATEC covers the entire value chain - from development to design and production through to quality assurance. The partners market the systems, software and consumables, in general together with their own reagents, as system solutions to laboratories, blood banks and research institutes around the world. STRATEC develops its products on the basis of its own patented technologies. Shares in the company are traded in the Prime Standard segment of the Frankfurt Stock Exchange.
 

Consejo de gestión & Consejo de supervisión

CEO
Marcus Wolfinger
Consejo de gestión
Dr. Claus Vielsack, Dr. Robert Siegle, Dr. Georg Bauer
Consejo de supervisión
Prof. Dr. Georg Heni, Dr. Frank Hiller, Dr. Rolf Vornhagen, Dr. Patricia Geller
 

Datos de la empresa

Nombre: STRATEC SE
Dirección: Gewerbestraße 37,D-75217 Birkenfeld
Teléfono: +49-7082-7916-0
Fax: +49-7082-7916-999
E-mail: info@stratec.com
Internet: www.stratec.com
Industria: Healthcare
Sector: Medical Products
Subsector: Advanced Medical Devices
Fin del año financiero: 31/12
Acciones de libre circulación: 35.57%
Fecha de OPI: 25/08/1998

Relación con inversores

Nombre: Jan Keppeler
IR teléfono: +49-7082-7916-991
IR-fax: +49-7082-7916-9190
IR e-mail: ir@stratec.com

Accionistas mayoritarios

Otros
 
86.96%
Invesco Ltd.
 
5.01%
Brown Capital Management, LLC
 
5.01%
Juno Investment Partners B.V
 
3.02%